Spots Global Cancer Trial Database for central chondrosarcoma, grade 2
Every month we try and update this database with for central chondrosarcoma, grade 2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | NCT04458922 | Central Chondro... Central Chondro... Dedifferentiate... Metastatic Clea... Metastatic Prim... Unresectable Pr... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... | 2 Years - | National Cancer Institute (NCI) | |
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | NCT04458922 | Central Chondro... Central Chondro... Dedifferentiate... Metastatic Clea... Metastatic Prim... Unresectable Pr... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... | 2 Years - | National Cancer Institute (NCI) |